These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9257048)

  • 1. Role of lipids in chronic renal allograft rejection.
    Swan SK
    Contrib Nephrol; 1997; 120():62-7. PubMed ID: 9257048
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring of lipid anomalies in renal transplantation].
    Mourad G; Vela C; Cristol JP
    Nephrologie; 2000; 21(7):365-6. PubMed ID: 11200613
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
    Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipids and lipoproteins alteration after renal transplantation.
    Mehrsai A; Khajehmougehi A; Afshar K; Emami M; Pourmand G
    Nephrol Dial Transplant; 1997 Jan; 12(1):233-4. PubMed ID: 9027812
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
    Friemann S; Feuring E; Padberg W; Ernst W
    Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504
    [No Abstract]   [Full Text] [Related]  

  • 6. No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure.
    Hillebrand GF; Schlosser S; Schneeberger H; Lorenz B; Zanker B; Samtleben W; Land W
    Transplant Proc; 1999; 31(1-2):1391-2. PubMed ID: 10083615
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of lipid-lowering agents on acute renal allograft rejection.
    Kasiske BL; Heim-Duthoy KL; Singer GG; Watschinger B; Germain MJ; Bastani B
    Transplantation; 2001 Jul; 72(2):223-7. PubMed ID: 11477342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection.
    Dimény E; Fellström B; Larsson E; Tufveson G; Lithell H
    Transplant Proc; 1992 Feb; 24(1):366. PubMed ID: 1539319
    [No Abstract]   [Full Text] [Related]  

  • 9. Dislipidemia at different immunosuppressive protocols.
    Zezina L; Rosental R
    Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of fish oil in cyclosporine-treated renal transplant recipients.
    Santos J; Queirós J; Silva F; Cabrita A; Rodrigues A; Henriques AC; Sarmento AM; Pereira MC; Guimarães S
    Transplant Proc; 2000 Dec; 32(8):2605-8. PubMed ID: 11134724
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyslipidemia and dietary modification in Chilean renal pediatric transplantation.
    Delucchi A; Marín V; Trabucco G; Azócar M; Salas P; Gutierrez E; Guardia S; Cano F; Cumsille MA
    Transplant Proc; 2001; 33(1-2):1297-301. PubMed ID: 11267300
    [No Abstract]   [Full Text] [Related]  

  • 12. Ciprofibrate and lipid profile.
    Chandler HA; Batchelor AJ
    Lancet; 1994 Jul; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
    Copley JB; Staffeld C; Lindberg J; Hansen A; Bailey C; Anand R; Van Veldhuisen P
    Transplant Proc; 1998 Jun; 30(4):1254-6. PubMed ID: 9636510
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis.
    Demirağ A; Moray G; Ozdemir N; Hizel N; Bilgin N; Haberal M
    Transplant Proc; 1998 Aug; 30(5):2052-3. PubMed ID: 9723389
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipid determination in current medical practice].
    Bakir R; Chanu B; Rouffy J
    Ann Dermatol Venereol; 1986; 113(9):855-9. PubMed ID: 3827091
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical correlation between renal allograft failure and hyperlipidemia.
    Guijarro C; Massy ZA; Kasiske BL
    Kidney Int Suppl; 1995 Dec; 52():S56-9. PubMed ID: 8587285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.
    Zawiasa A; Nowicki M
    Metabolism; 2013 Oct; 62(10):1462-9. PubMed ID: 23866980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile before and after renal transplantation--a longitudinal study.
    Pannu HS; Singh D; Sandhu JS
    Ren Fail; 2003 May; 25(3):411-7. PubMed ID: 12803504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation in renal allograft recipients.
    Juskowa J; Paczek L; Barańska E; Rancewicz Z; Stryjecka-Rowińska D; Gradowska L; Wyzgał J; Senatorski G; Cieplak M
    Transplant Proc; 1996 Dec; 28(6):3474-6. PubMed ID: 8962351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.